140 related articles for article (PubMed ID: 1445623)
1. Simplified dosing and monitoring of vancomycin for the burn care clinician.
Rice TL
Burns; 1992 Oct; 18(5):355-61. PubMed ID: 1445623
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review of Vancomycin Dosing and Monitoring in Burn Patients.
Carter BL; Damer KM; Walroth TA; Buening NR; Foster DR; Sood R
J Burn Care Res; 2015; 36(6):641-50. PubMed ID: 25423436
[TBL] [Abstract][Full Text] [Related]
3. Optimizing initial vancomycin dosing in burn patients.
Elligsen M; Walker SA; Walker SE; Simor A
Burns; 2011 May; 37(3):406-14. PubMed ID: 21095062
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
6. [Continuous administration of vancomycin in patients with severe burns].
Conil JM; Favarel H; Laguerre J; Brouchet A; Chabanon G; Cazal L; Bodnar M; Rougé D; Virenque C; Costagliola M
Presse Med; 1994 Nov; 23(34):1554-8. PubMed ID: 7824489
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin pharmacokinetics in patients with severe burn injuries.
Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
[TBL] [Abstract][Full Text] [Related]
8. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL
Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
10. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
[TBL] [Abstract][Full Text] [Related]
12. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Yang RH; Rong XZ; Hua R; Zhang T
Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
16. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice.
Elbarbry F
Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):259-268. PubMed ID: 29260505
[TBL] [Abstract][Full Text] [Related]
18. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
Eiland LS; English TM; Eiland EH
Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
[TBL] [Abstract][Full Text] [Related]
20. How vancomycin is used in Australasia--a survey.
Duffull SB; Chambers ST; Begg EJ
Aust N Z J Med; 1993 Dec; 23(6):662-6. PubMed ID: 8141694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
